KAYA
|
KAYA Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -89.15 | -52.69 | -29.10 | -41.66 | -12.22 |
| CEPS(Rs) | -17.58 | 13.75 | 17.40 | 16.19 | 11.74 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | -81.58 | -2.17 | 41.70 | 60.61 | 119.02 |
| Tax Rate(%) | - | - | - | -63.76 | 28.75 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 3.73 | 8.32 | 9.80 | 14.15 | 3.56 |
| EBIT Margin(%) | -19.84 | -14.57 | -6.70 | -2.80 | -2.36 |
| Pre Tax Margin(%) | -30.86 | -20.98 | -13.61 | -8.40 | -4.59 |
| PAT Margin (%) | -30.86 | -20.98 | -13.61 | -13.76 | -3.27 |
| Cash Profit Margin (%) | -6.10 | 5.55 | 8.27 | 5.38 | 3.64 |
| Performance Ratios | |||||
| ROA(%) | -31.81 | -18.64 | -9.58 | -14.21 | -3.93 |
| ROE(%) | - | -263.21 | -55.98 | -46.11 | -7.57 |
| ROCE(%) | -121.62 | -53.94 | -18.27 | -7.24 | -4.65 |
| Asset Turnover(x) | 1.03 | 0.89 | 0.70 | 1.03 | 1.20 |
| Sales/Fixed Asset(x) | 0.84 | 0.76 | 0.67 | 1.18 | 1.66 |
| Working Capital/Sales(x) | -3.55 | -3.59 | -2.65 | -4.18 | -6.42 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.20 | 1.32 | 1.48 | 0.85 | 0.60 |
| Receivable days | 3.57 | 4.02 | 5.61 | 4.89 | 3.96 |
| Inventory Days | 27.33 | 30.75 | 42.24 | 36.76 | 37.46 |
| Payable days | 1,177.87 | 1,829.08 | 1,518.93 | 1,058.80 | 1,523.06 |
| Valuation Parameters | |||||
| PER(x) | - | - | - | - | - |
| PCE(x) | -14.41 | 25.48 | 17.03 | 6.88 | 60.97 |
| Price/Book(x) | -3.10 | -161.21 | 7.11 | 1.84 | 6.01 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.11 | 1.60 | 1.49 | 0.43 | 2.26 |
| EV/Core EBITDA(x) | 22.59 | 13.37 | 9.83 | 2.61 | 49.70 |
| EV/EBIT(x) | -5.60 | -10.98 | -22.27 | -15.21 | -95.52 |
| EV/CE(x) | 1.13 | 1.43 | 1.11 | 0.41 | 2.72 |
| M Cap / Sales | 0.88 | 1.41 | 1.41 | 0.37 | 2.22 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 16.29 | 17.82 | -30.07 | -6.57 | 5.12 |
| Core EBITDA Growth(%) | -52.11 | -7.17 | -35.07 | 235.85 | 62.20 |
| EBIT Growth(%) | -58.39 | -156.16 | -67.36 | -10.61 | 20.42 |
| PAT Growth(%) | -71.08 | -81.66 | 30.86 | -293.44 | 27.27 |
| EPS Growth(%) | -69.19 | -81.09 | 30.15 | -240.91 | 24.66 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | -1.33 | -30.33 | 0.66 | 0.37 | 0.22 |
| Current Ratio(x) | 0.57 | 0.54 | 0.43 | 0.50 | 0.64 |
| Quick Ratio(x) | 0.45 | 0.40 | 0.28 | 0.31 | 0.40 |
| Interest Cover(x) | -1.80 | -2.27 | -0.97 | -0.50 | -1.06 |
| Total Debt/Mcap(x) | 0.43 | 0.19 | 0.09 | 0.20 | 0.04 |
Compare Financial Ratios of peers of KAYA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KAYA | ₹449.3 Cr | -2.8% | -12.1% | 19.4% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹90,042.3 Cr | 3.4% | -6.6% | 49% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹79,011.6 Cr | 5.7% | -8.7% | 59.1% | Stock Analytics | |
| GLOBAL HEALTH | ₹38,724.1 Cr | 6.7% | -13.1% | 164.4% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹33,995.8 Cr | 2.6% | -6.4% | 59.4% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹25,809.8 Cr | 2% | -9.6% | 59.5% | Stock Analytics | |
KAYA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KAYA | -2.8% |
-12.1% |
19.4% |
| SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses
